Launch event: Is this the new era? Funding for sexual & reproductive health and women's health R&D

Join us for the launch of our latest report that examines the state of global funding for LMIC-applicable biomedical R&D targeting a range of sexual & reproductive health and women’s health issues.

Since 2018, we’ve tracked funding for R&D targeting sexually transmitted infections, HPV and HPV-related cancers, contraception, multipurpose prevention technologies (MPTs), preeclampsia/eclampsia, and postpartum haemorrhage. In 2023, we significantly expanded the G-FINDER survey to shine a light on long-overlooked conditions that uniquely affect women, including endometriosis, polycystic ovary syndrome, uterine fibroids, menopause, maternal iron deficiency anaemia, preterm labour, and abortion.

For the first time, this report brings together comprehensive funding data for all these conditions and provides a clear picture of who is funding what, and where the biggest gaps remain.

We’re delighted to announce Dr Nigina Muntean as our guest for the event, where we’ll discuss how these insights can be applied to advocacy efforts shaping the future of SRH and women's health innovation.

We hope you can join us to discuss these findings and how they can be applied to shape a more equitable and impactful R&D agenda for SRH and women’s health worldwide.